Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients

Seminars in Oncology

Volumn 23, Issue 6 SUPPL. 13, 1996, Pages 23-29

  Kaul, S ^a   Srinivas, N R ^a   Mummaneni, V ^a   Igwemezie, L N ^a   Barbhaiya, R H ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOFOS;

ADULT; AGE; AGED; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; DRUG EFFECT; DRUG HALF LIFE; FEMALE; GENDER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; CONTINENTAL POPULATION GROUPS; DATA INTERPRETATION, STATISTICAL; ETOPOSIDE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; SEX FACTORS;

EID: 0030450101     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)